| Immune-resistant mechanisms in cancer immunotherapy Y Kawakami, S Ohta, MA Sayem, N Tsukamoto, T Yaguchi International Journal of Clinical Oncology 25, 810-817, 2020 | 52 | 2020 |
| Identification of glypican-3-derived long peptides activating both CD8+ and CD4+ T cells; prolonged overall survival in cancer patients with Th cell response MA Sayem, Y Tomita, A Yuno, M Hirayama, A Irie, H Tsukamoto, S Senju, ... Oncoimmunology 5 (1), e1062209, 2016 | 43 | 2016 |
| Using chitosan or chitosan derivatives in cancer therapy MS Shakil, KM Mahmud, M Sayem, MS Niloy, SK Halder, MS Hossen, ... Polysaccharides 2 (4), 795-816, 2021 | 37 | 2021 |
| Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm MFU Rahman, Y Yang, BT Le, A Dutta, J Posyniak, P Faughnan, ... Nature Communications 13 (1), 5347, 2022 | 27 | 2022 |
| An oncofetal antigen, IMP-3-derived long peptides induce immune responses of both helper T cells and CTLs M Hirayama, Y Tomita, A Yuno, H Tsukamoto, S Senju, Y Imamura, ... OncoImmunology 5 (6), e1123368, 2016 | 24 | 2016 |
| Identification of immunogenic LY6K long peptide encompassing both CD4+ and CD8+ T-cell epitopes and eliciting CD4+ T-cell immunity in patients with malignant disease Y Tomita, A Yuno, H Tsukamoto, S Senju, Y Kuroda, M Hirayama, ... Oncoimmunology 3 (3), e28100, 2014 | 21 | 2014 |
| Differential host immune responses to epidemic and endemic strains of Shigella dysenteriae type 1 MA Sayem, SM Ahmad, RS Rekha, P Sarker, B Agerberth, KA Talukder, ... Journal of health, population, and nutrition 29 (5), 429, 2011 | 20 | 2011 |
| Establishment of HLA-DR4 Transgenic Mice for the Identification of CD4+ T Cell Epitopes of Tumor-Associated Antigens J Yatsuda, A Irie, K Harada, Y Michibata, H Tsukamoto, S Senju, Y Tomita, ... PLoS One 8 (12), e84908, 2013 | 13 | 2013 |
| Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors T Kinoshita, MA Sayem, T Yaguchi, B Kharma, K Morii, D Kato, S Ohta, ... Cancer science 112 (4), 1390-1401, 2021 | 9 | 2021 |
| Microwave-assisted activated carbon: a promising class of materials for a wide range of applications MNM Ansari, MA Sayem Radiation technologies and applications in materials science, 331-368, 2022 | 2 | 2022 |
| Genetic deletion or pharmacologic inhibition of PTPN11 impedes the development and progression of myeloproliferative neoplasms induced by JAK2V617F and MPLW515L mutants G Mohi, Y Yang, MA Sayem, BT Le, F Ather, A Dutta, S Abbas Blood 142, 739, 2023 | 1 | 2023 |
| Effect of activation temperature on the performance of Chitosan-based activated carbon for super-capacitor application MA Sayem, MA Hannan, MNM Ansari, AQ Al-Shetwi, KM Muttaqi 2022 IEEE Industry Applications Society Annual Meeting (IAS), 1-8, 2022 | 1 | 2022 |
| Fuzzy based BSA optimization for maximum power point tracking controller performance evaluation MA Sayem, A Nadzirah, AQ Al-Shetwi, MA Hannan, PJ Ker, SA Rahman, ... 2021 IEEE industry applications society annual meeting (IAS), 1-8, 2021 | 1 | 2021 |
| Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA … MF Uddin, MA Khan, S Selim, N Sultana, MA Sayem, MM Iftekhar, ... Journal of Comparative Effectiveness Research 13 (2), e230132, 2024 | | 2024 |
| SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm Y Yang, S Abbas, MA Sayem, A Dutta, G Mohi Blood Cancer Journal 171 (13), 2023 | | 2023 |
| Using Chitosan or Chitosan Derivatives in Cancer Therapy. Polysaccharides 2021, 2, 795–816 MS Shakil, KM Mahmud, M Sayem, MS Niloy, SK Halder, MS Hossen, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
| PD-1 expressing ex-vivo cultured tumor infiltrating lymphocytes confers tumor reactivity in cervical cancer: Possible implication for adoptive cell therapy MA Sayem, N Sunthamala, T Yaguchi, T Iwata, T Fujita, Y Kawakami Cancer Research 80 (16_Supplement), 1066-1066, 2020 | | 2020 |
| Identification of promiscuous oncofetal antigen (IMP-3)-derived long peptides, bearing both Th cell and CTL epitopes M Hirayama, A Yuno, Y Tomita, MA Sayem, H Tsukamoto, A Irie, S Senju, ... Cancer Research 75 (15_Supplement), 2500-2500, 2015 | | 2015 |
| Efficient crosspresentation of oncofetal antigen (Glypican-3)-derived long peptides encompassing CTL and promiscuous Th cell epitopes using a novel liposome MA Sayem, Y Tomita, A Yuno, M Hirayama, A Irie, H Tsukamoto, S Senju, ... Cancer Research 75 (15_Supplement), 2503-2503, 2015 | | 2015 |
